首页> Osteoarthritis and cartilage> Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: A randomized, double-blind, dose-escalation, placebo-controlled study

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: A randomized, double-blind, dose-escalation, placebo-controlled study

导出原文传递

翻译打印收藏纠错

第一作者： Nagashima,H.

作者： Nagashima,H. ^[1] ; Suzuki,M. ^[2] ; Araki,S. ; Yamabe,T. ; Muto,C.

作者单位： Pfizer Japan Inc., Tokyo, Japan ^[1] Yanagibashi-Clinical Trial Center, Yanagibashi Hospital, Life Extension Research Institute ^[2]

关键词 Japan Monoclonal antibody Nerve growth factor Osteoarthritis Pain Tanezumab

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Osteoarthritis and cartilage

2011年19卷12期

1405-1412页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Osteoarthritis and cartilage

2011年19卷12期

1405-1412页

检索历史清除

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: A randomized, double-blind, dose-escalation, placebo-controlled study

Osteoarthritis and cartilage

相似文献

同项目论文

Osteoarthritis and cartilage

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: A randomized, double-blind, dose-escalation, placebo-controlled study

Osteoarthritis and cartilage

相似文献

同项目论文

Osteoarthritis and cartilage

相关期刊

检索历史清除